메뉴 건너 뛰기
SinilPharm

Financial Information

BalanceSheet

Financial items 2018, 12 2017, 12 2016, 12
Price Composition Growth Price Composition Growth Price Composition Growth
TOTAL CURRENT ASSETS 47,022 44.2 ▼-1.3 48,131 45.9 ▼-10.5 53,787 54.9 ▲17.4
TOTAL NON-CURRENT ASSETS 59,382 55.8 ▲8.2 56,630 54.1 ▲27.9 44,266 45.1 ▲6.8
TOTAL ASSETS 106,404 100 ▲3.8 104,761 100 ▲6.8 98,053 100 ▲12.4
TOTAL CURRENT LIABILITIES 7,403 7 ▼-10.5 7,813 7.5 ▲5.9 7,378 7.5 ▲5.2
TOTAL NON-CURRENT LIABILITIES 3,816 3.6 ▲14.9 3,321 3.2 ▼-4.7 3,485 3.6 ▲68
TOTAL LIABILITIES 11,219 10.5 ▼-3.2 11,135 10.6 ▲2.5 10,863 11.1 ▲19.5
Capital stocks 3,950 3.7 0 3,950 3.8 0 3,950 4 0
Capital surplus 2,671 2.5 0 2,671 2.5 0 2,671 2.7 0
Retained earnings 88,635 83.3 ▲5 87,076 83.1 ▲8 80,640 82.2 ▲12.6
TOTAL STOCKHOLDERS' EQUITY 95,185 89.5 ▲4.7 93,626 89.4 ▲7.4 87,190 88.9 ▲11.5

Income Statement

Financial items 2018, 12 2017, 12 2016, 12
Price Composition Growth Price Composition Growth Price Composition Growth
SALES(NET) 53,277 100 ▲4.6 50,942 100 ▲1.5 50,212 100 ▲12.3
GROSS PROFIT 20,886 39.2 ▼-7.6 22,571 44.3 ▼-5.4 23,847 47.5 ▲8.1
OPERATING INCOME 6,021 11.3 ▼-34.8 9,261 18.2 ▼-18.4 11,348 22.6 ▲7.9
NON-OPERATING INCOME 576 1.1 ▼-18.9 710 1.4 ▲2.2 695 1.4 ▼-7.4
NON-OPERATING EXPENSES 818 1.5 ▲70.7 1,249 2.5 ▲307.8 306 .6 ▼-57.3
NET INCOME 5,714 10.7 ▼-30.3 7,591 14.9 ▼-24.4 10,038 20 ▲14.5

Cash Flow Statement

Financial items 2018년 12월 2017년 12월 2016년 12월
Composition On changes Composition On changes Composition On changes
Cash flows from operating activities 9,194 ▲6 8,951 ▲111.4 4,235 ▼-55.7
Cash flows from investing activities -8,816 ▼-45.8 -6,258 ▼-32.6 -4,720 ▲53.8
CF from financing act. -909 ▼-.9 -968 ▲7.6 -1,049 ▼-82.7
Increases(Decreases) in cash -531 ▼-130.8 1,725 ▲212.4 -1,534 ▼-25.1
Cash at the beginning of the period 2,262 ▲320.7 538 ▼-74 2,071 ▼-37.2
Cash at the end of the period 1,727 ▼-23.7 2,262 ▲320.7 538 ▼-74